| Literature DB >> 36119356 |
Itishree Dubey1, Sabbir Khan2, Sapana Kushwaha1.
Abstract
Microplastics (MPs), small pieces of plastic (∼5 mm), are released into the environment not only as a result of the decomposition of large-sized plastics but also from day-to-day use of plastic products. Chronic exposure to MPs has been attributed to harmful effects on aquatic organisms and rodents. Effects include gastrointestinal toxicity, hepatotoxicity, neurotoxicity, and reproductive and developmental toxicities. Exposure to MPs may also potentially affect human health. Herein, we reviewed the impact of MPs on male and female reproductive systems and the associated mechanisms involved in the reproductive and developmental toxicities of MPs. We performed a literature search in Google Scholar and PubMed using the following keywords: MPs and reproductive toxicity; MPs and developmental studies; MPs and infertility; MPs and aquatics; and MPs and rodents. Evidence of MPs accumulation has been reported in many organs of humans and experimental models. The harmful effects of MPs have been manifested in male and female reproductive systems of mammalian and aquatic animals, including developmental effects on gametes, embryos, and their offspring. This review describes various signaling pathways involved in MPs-associated male and female reproductive and developmental toxicities.Entities:
Keywords: BTB-blood–testis barrier; MPs-microplastics; developmental toxicity; reproductive toxicity; signaling
Year: 2022 PMID: 36119356 PMCID: PMC9471315 DOI: 10.3389/ftox.2022.901798
Source DB: PubMed Journal: Front Toxicol ISSN: 2673-3080
FIGURE 1Schematic diagram showing microplastics affecting male and female reproductive functions: Microplastics affecting male reproductive functions via the activation of different signaling pathways, Akt/mTOR, apoptosis, MAPK, and inhibition of cAMP/PK3 that results in increased oxidative stress, BTB disruption, and spermatogenesis dysfunction and decrease in steroidogenic enzymes and LHR downregulation. Microplastics affecting the female reproductive functions altered by the activation of NLRP3, TLR4/NOX2, and TGF-β/fibrogenesis that results in increased oxidative stress, endometrial thinning, collagen deposition, inflammatory markers, and pyroptosis and apoptosis of granulosa cells while ovarian reserve, growing follicles, granulosa cells capacity, and anti-müllerian hormone levels are decreased. Abbreviations: cAMP, cyclic adenosine monophosphate; AKT, Ak strain transforming; BTB, blood–testes barrier; LHR, luteinizing hormone receptor; MAPK, mitogen-activated protein kinase; mTOR, mammalian target of rapamycin; NOX-2, NADPH oxidase-2; NLRP3, nod-like receptor family pyrin domain containing 3; PKA, protein kinase A; StAR, steroidogenic acute regulatory protein; TGF-β, transforming growth factor-β; TLR4, toll-like receptor-4.
Summary of experimental studies showing developmental and harmful effects of MPs in different species and their offspring.
| S.N | Type of toxicity | Model systems | MPs types | MPs sizes and concentrations used | Reported effects and inferences | Reference |
|---|---|---|---|---|---|---|
| 1 | Developmental toxicity (postnatal) |
| Pristine polymer microspheres | 1–5 μm (0.1 mg/L) | Decreased growth, reproduction, and population growth rate led to the extinction of F1 generation |
|
| MPs deposition was seen until F3 generation | ||||||
| 2 | Developmental toxicity (postnatal and prenatal) | Marine medaka ( | PS- MPs | 10 µm (20 and 200 mg/L) | Delayed incubation time reduced the heart and hatching rate and length of body of the offspring |
|
| 3 | Developmental toxicity (postnatal) | Marine medaka ( | PS-MPs (Phenanthrene) | 10 μm (2–200 μg/L) | Higher dose deposited on the chorion reduced the growth and hatching rate and delayed hatching time. MPs at low dose do not accumulate phenanthrene |
|
| 4 | Developmental toxicity (prenatal and postnatal), and reproductive toxicity | Marine medaka (O | MPs + Phenanthrene | 13 μm (200 μg/L) | Exacerbated bradycardia in embryos, causing transgenerational toxicity from mother to offspring |
|
| 5 | Developmental toxicity (postnatal) | Zebrafish ( | Polyamide (PA) MPs | 6.37–8.13 μm 200 mg/L | Reduced hatching rate and inhibited musculoskeletal development in zebrafish larvae |
|
| Macrophages induced proinflammation, apoptosis, and multi-xenobiotics resistance | ||||||
| 6 | Developmental toxicity (postnatal) | Zebrafish ( | Pristine PE-MPs (Medium density) | 20–60 μm (6.2, 12.5, 25.0, 50.0 and 100 mg/L) | Harmful effects such as bigger swim bladder, increased yolk sac, and reduced hatching rate of larvae |
|
| Larvae at concentrations of 50 and 100 mg/L MPs showed more significant external morphological changes and higher teratogenic abnormality rates | ||||||
| 7 | Developmental toxicity (prenatal and postnatal) | Zebrafish ( | Pristine PS- MPs + Butylated hydroxyanisole (BHA) | 65 nm to 20 μm, (2 mg/L) and (BHA, 1 mg/L) | MPs aggravate the accumulation of BHA in zebrafish larvae viz. reduced hatching rates, increased malformation rates, and decreased calcified vertebrae |
|
| 8 | Developmental toxicity (prenatal and postnatal) | Zebrafish ( | Pristine PE-MPs and spiked with benzo α pyrene (MP-BaP) | 20–27 µm (1% w/w in the fish diet) | MPs and MP-BaP 30 and 90 dpf (day post-fertilization) lead to altered growth parameters such as reduced fecundity, egg morphology, and yolk area |
|
| Impairment in the development of caudal fins and bone quality | ||||||
| 9 | Developmental toxicity (prenatal and postnatal) | Zebrafish ( | PS- MPs | 10 μm (200 particles/mL) | Larvae development deformities, moderate hatching rate, and altered antioxidant and cellular function |
|
| 10 | Developmental (prenatal) and reproductive toxicity | Prawn | PS-MPs | (2 and 20 mg/L) | The quality of testicular germ cells and sex hormones are altered, causing decreased hatching success and survival of F1 larvae. PS-MPs bioaccumulated in different tissues of larvae and decreased immunity due to paternal exposure |
|
| 11 | Developmental and (prenatal and postnatal) reproductive toxicity | Mice | PS nanoplastics | 100 nm (0.1, 1 and 10 mg/L) | Prenatal and postnatal PS-NPs exposure declines birth and postnatal body weight in offspring |
|
| Transgenerational testicular toxicities in offspring (reduced testis weight and sperm counts) | ||||||
| 12 | Developmental toxicity (postnatal) | ICR Mice | PS- MPs | 0.5 and 5 µm (100 and 1,000 μg/L) | Risk of metabolic disorders in offspring |
|
| Intergenerational effects on the F1 offspring | ||||||
| 13 | Developmental (prenatal and postnatal) reproductive toxicity | Male and female ICR mice | PE-MPs | 40–48 μm (0.125, 0.5, and 2 mg/mouse) | Reduced number of live births/dam, sex ratio, and body weight of pups |
|
| Immune disruption in the offspring of PE-treated maternal or paternal mice | ||||||
| 14 | Developmental toxicity (prenatal) | C57BL/6-mated Balb/c mice (Allogenic mice) | PS-MPs | 10 μm (250 μg/mouse) | Increased resorption rate and reduced number and diameter of uterine arterioles |
|
| Immunological barrier homeostasis disruption in the peripheral blood, placenta, and spleen |